Gavin J. Churchyard - Publications

Restoring certainty to global health regulation.

Journal: BMJ (Clinical research ed.)

Published: May 06, 2026

Threshold cost of delivering preventive treatment for household contacts of people with multidrug-resistant TB.

Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease

Published: April 28, 2026

Guiding principles for pragmatic randomised trials of tuberculosis treatments.

Journal: The Lancet. Infectious diseases

Published: March 30, 2026

Design and feasibility considerations for a phase 3 efficacy trial of the M72/AS01E-4 tuberculosis vaccine.

Journal: Vaccine

Published: March 18, 2026

The role of interferon-gamma release assays in tuberculosis vaccine trials: strengths, limitations, and implications beyond trial design.

Journal: Vaccine

Published: March 18, 2026

Inflammatory biomarkers of asymptomatic and symptomatic tuberculosis.

Journal: Nature communications

Published: March 13, 2026

A proteome-wide atlas of humoral immunity to Mycobacterium tuberculosis across the spectrum of disease.

Journal: Frontiers in immunology

Published: February 13, 2026

New tuberculosis vaccines for people with HIV.

Journal: AIDS (London, England)

Published: December 03, 2025

Correction: Epidemiological factors associated with immunological resistance in household contacts exposed to active tuberculosis in South Africa: A logistic regression analysis.

Journal: PloS one

Published: November 25, 2025

Inflammatory Biomarkers of Asymptomatic and Symptomatic Tuberculosis.

Journal: bioRxiv : the preprint server for biology

Published: November 24, 2025

Whole genome sequencing precision medicine strategy to shorten treatment for rifampicin-resistant tuberculosis (SMARTT): a pragmatic, randomised, single-blind phase 4 trial.

Journal: The Lancet. Respiratory medicine

Published: October 31, 2025

Real-time electronic drug monitoring: experiences from a multinational phase 3 clinical trial to prevent multidrug-resistant TB.

Journal: IJTLD open

Published: October 28, 2025